ULTRAZYME PLUS GPT

Nadh Oxidation/nad Reduction, Alt/sgpt

HARLECO

The following data is part of a premarket notification filed by Harleco with the FDA for Ultrazyme Plus Gpt.

Pre-market Notification Details

Device IDK780102
510k NumberK780102
Device Name:ULTRAZYME PLUS GPT
ClassificationNadh Oxidation/nad Reduction, Alt/sgpt
Applicant HARLECO 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeCKA  
CFR Regulation Number862.1030 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1978-01-20
Decision Date1978-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.